MarketScreener Strategies Spyre Therapeutics, Inc.
Equities
SYRE
US00773J2024
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.59 USD | -1.00% |
|
-5.93% | +23.90% |
| Feb. 23 | Deutsche Bank Adjusts Spyre Therapeutics PT to $55 From $45, Maintains Buy Rating | MT |
| Feb. 20 | Top Midday Gainers | MT |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- SYRE Stock
- News Spyre Therapeutics, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
